These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21106380)

  • 21. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
    Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
    Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 35 kDa NAD(P)H oxidase previously isolated from the archaeon Sulfolobus solfataricus is instead a thioredoxin reductase.
    Ruocco MR; Ruggiero A; Masullo L; Arcari P; Masullo M
    Biochimie; 2004 Dec; 86(12):883-92. PubMed ID: 15667938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function of Glu-469' in the acid-base catalysis of thioredoxin reductase from Drosophila melanogaster.
    Huang HH; Arscott LD; Ballou DP; Williams CH
    Biochemistry; 2008 Dec; 47(48):12769-76. PubMed ID: 18991392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation of hypericins in Hypericum triquetrifolium Turra growing in different locations of Turkey during plant growth.
    Ayan AK; Cirak C
    Nat Prod Res; 2008 Dec; 22(18):1597-604. PubMed ID: 19085414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the developmental stage on the (proto)-hypericin and (proto)pseudohypericin levels of Hypericum plants from Crete.
    Xenophontos M; Stavropoulos E; Avramakis E; Navakoudis E; Dörnemann D; Kotzabasis K
    Planta Med; 2007 Oct; 73(12):1309-15. PubMed ID: 17893828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster.
    Kanzok SM; Fechner A; Bauer H; Ulschmid JK; Müller HM; Botella-Munoz J; Schneuwly S; Schirmer R; Becker K
    Science; 2001 Jan; 291(5504):643-6. PubMed ID: 11158675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypericins as potential leads for new therapeutics.
    Karioti A; Bilia AR
    Int J Mol Sci; 2010 Feb; 11(2):562-94. PubMed ID: 20386655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
    Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
    Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the specificity of thioredoxin reductase-thioredoxin interactions. A structural and functional investigation of the yeast thioredoxin system.
    Oliveira MA; Discola KF; Alves SV; Medrano FJ; Guimarães BG; Netto LE
    Biochemistry; 2010 Apr; 49(15):3317-26. PubMed ID: 20235561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney.
    Crosley LK; Méplan C; Nicol F; Rundlöf AK; Arnér ES; Hesketh JE; Arthur JR
    Arch Biochem Biophys; 2007 Mar; 459(2):178-88. PubMed ID: 17291446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of apoptosis by the overexpression of an alternative splicing variant of mitochondrial thioredoxin reductase.
    Chang EY; Son SK; Ko HS; Baek SH; Kim JH; Kim JR
    Free Radic Biol Med; 2005 Dec; 39(12):1666-75. PubMed ID: 16298692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of an active site mutant of the selenoprotein thioredoxin reductase: the Ser-Cys-Cys-Ser motif of the insect orthologue is not sufficient to replace the Cys-Sec dyad in the mammalian enzyme.
    Johansson L; Arscott LD; Ballou DP; Williams CH; Arnér ES
    Free Radic Biol Med; 2006 Aug; 41(4):649-56. PubMed ID: 16863998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.
    Brockmöller J; Reum T; Bauer S; Kerb R; Hübner WD; Roots I
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():94-101. PubMed ID: 9342768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
    Draves AH; Walker SE
    Can J Clin Pharmacol; 2003; 10(3):114-8. PubMed ID: 14506510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-linking of thioredoxin reductase by the sulfur mustard analogue mechlorethamine (methylbis(2-chloroethyl)amine) in human lung epithelial cells and rat lung: selective inhibition of disulfide reduction but not redox cycling.
    Jan YH; Heck DE; Malaviya R; Casillas RP; Laskin DL; Laskin JD
    Chem Res Toxicol; 2014 Jan; 27(1):61-75. PubMed ID: 24274902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of enantiomerization barriers of hypericin and pseudohypericin by dynamic high-performance liquid chromatography on immobilized polysaccharide-type chiral stationary phases and off-column racemization experiments.
    Ciogli A; Bicker W; Lindner W
    Chirality; 2010 May; 22(5):463-71. PubMed ID: 19644936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver.
    Lee SR; Kim JR; Kwon KS; Yoon HW; Levine RL; Ginsburg A; Rhee SG
    J Biol Chem; 1999 Feb; 274(8):4722-34. PubMed ID: 9988709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomimetic studies on selenoenzymes: modeling the role of proximal histidines in thioredoxin reductases.
    Sarma BK; Mugesh G
    Inorg Chem; 2006 Jul; 45(14):5307-14. PubMed ID: 16813393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.